Filing Details
- Accession Number:
- 0001181431-11-030522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-17 18:24:58
- Reporting Period:
- 2011-05-17
- Filing Date:
- 2011-05-17
- Accepted Time:
- 2011-05-17 18:24:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1453814 | Medidata Solutions Inc. | MDSO | Services-Prepackaged Software (7372) | 522319066 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237855 | D Bruce Dalziel | C/O Medidata Solutions, Inc. 79 Fifth Avenue, 8Th Floor New York NY 10003 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-17 | 12,000 | $12.08 | 68,839 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-17 | 12,000 | $22.04 | 56,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2011-05-17 | 12,000 | $0.00 | 12,000 | $12.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 185,000 | 2017-10-02 | No | 4 | M | Direct |
Footnotes
- The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2011.
- Such transaction was executed in multiple trades at prices ranging from $21.43 to $22.44. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- These options vested and become exercisable as to 25% of the underlying shares on September 10, 2008 and the remaining vest ratably each month over three years thereafter.
Billionaire Hedge Funds
